C07D 239/22
With hetero atoms directly attached to ring carbon atoms
Official title: with hetero atoms directly attached to ring carbon atoms
C07D239/22 (With hetero atoms directly attached to ring carbon atoms) appears on 325 US grants and 321 published applications in this corpus.
Search patents in C07D- Granted patents
- 325
- Published applications
- 321
- Assignees
- 211
- Inventors
- 1,161
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 2 |
| 2002 | 6 | 11 |
| 2003 | 2 | 11 |
| 2004 | 9 | 14 |
| 2005 | 4 | 7 |
| 2006 | 7 | 14 |
| 2007 | 4 | 6 |
| 2008 | 3 | 16 |
| 2009 | 7 | 11 |
| 2010 | 9 | 17 |
| 2011 | 9 | 13 |
| 2012 | 17 | 20 |
| 2013 | 15 | 15 |
| 2014 | 17 | 19 |
| 2015 | 21 | 16 |
| 2016 | 8 | 12 |
| 2017 | 11 | 6 |
| 2018 | 11 | 20 |
| 2019 | 10 | 8 |
| 2020 | 11 | 17 |
| 2021 | 11 | 13 |
| 2022 | 8 | 13 |
| 2023 | 5 | 18 |
| 2024 | 7 | 8 |
| 2025 | 8 | 7 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Eco-friendly insecticidal agent against Aphis gossypii(glover.) insect4 Aug 2026US 12,696,903 B1King Faisal University
- Cyano-pyrimidine inhibitors of EGFR/HER24 Aug 2026US 12,698,261 B2Dana-Farber Cancer Institute, Inc.
- Styryl carboxylate derivatives26 May 2026US 12,637,409 B2Renovel Innovations, Inc.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Compounds and methods for degrading gspt124 Sep 2026US 2026/0285872 A1Pin Therapeutics, Inc.
- New e3 ubiquitin ligase ligand, protein degradation agent and use thereof17 Sep 2026US 2026/0274829 A1Gluetacs Therapeutics (Shanghai) Co., Ltd.
- Novel compounds6 Aug 2026US 2026/0226031 A1NRG Therapeutics Ltd
- Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors19 Mar 2026US 2026/0078105 A1OrsoBio, Inc.
Most cited
By later US patents
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present79US 5,270,317 AElf Sanofi · 1993
- THF-containing sulfonamide inhibitors of aspartyl protease53US 5,723,490 AVertex Pharmaceuticals Incorporated · 1998
- Sulfonamide inhibitors of aspartyl protease50US 6,372,778 B1Vertex Pharmaceuticals Incorporated · 2002